Freedom of Information Request Reference: 8312
Date Received: 03/05/2024
Summary:
Please provide the following information: As of 1 Jan 2024: • Total population size served by Regional Board • Number of hospitals providing oncology services • Total number of consultant haematologists employees; specialist haematology registrars employed; consultant haematologists specialising in multiple myeloma; haematology clinical nurse specialists employed and multiple myeloma clinical nurse specialists. During 2023 (1 Jan – 31 Dec), please provide the: • Total number of multiple myeloma (MM) cases diagnosed (Please state which code(s) were used) • If known, how many people were diagnosed with smouldering multiple myeloma? • How many in-person haematology-based consultation/telephone haematology-based consultations/ video haematology-based consultation took place for people diagnosed with MM? During 2023 (1 Jan – 31 Dec): • Were multiple myeloma (MM) patients discussed/reviewed at a MM specific MDT or general haematology MDT? • How frequently did MDT meetings meet? • What percentage of MM patients diagnosed in 2023 were reviewed/discussed at a MDT? • Which professionals/disciplines are represented on MDT meetings for MM? • What supportive and palliative care services are available for MM patients?
Please provide the following information: As of 1 Jan 2024: • Total population size served by Regional Board • Number of hospitals providing oncology services • Total number of consultant haematologists employees; specialist haematology registrars employed; consultant haematologists specialising in multiple myeloma; haematology clinical nurse specialists employed and multiple myeloma clinical nurse specialists. During 2023 (1 Jan – 31 Dec), please provide the: • Total number of multiple myeloma (MM) cases diagnosed (Please state which code(s) were used) • If known, how many people were diagnosed with smouldering multiple myeloma? • How many in-person haematology-based consultation/telephone haematology-based consultations/ video haematology-based consultation took place for people diagnosed with MM? During 2023 (1 Jan – 31 Dec): • Were multiple myeloma (MM) patients discussed/reviewed at a MM specific MDT or general haematology MDT? • How frequently did MDT meetings meet? • What percentage of MM patients diagnosed in 2023 were reviewed/discussed at a MDT? • Which professionals/disciplines are represented on MDT meetings for MM? • What supportive and palliative care services are available for MM patients?
Date of Response: 03/05/2024
View Response: 8312.pdf
View Response: 8312.pdf